Root Financial Partners
VIR icon

Root Financial Partners’s Vir Biotechnology VIR Stock Holding History

Root Financial Partners’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.41K Buy
+305
New +$3.05K ﹤0.01% 2388
2026
Q2 		– Sell
-243
Closed -$2.18K – 3093
2026
Q1 		$2.18K Buy
+243
New +$1.94K ﹤0.01% 2281

Other funds holding VIR

GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Root Financial Partners's VIR Position: Q3 2026 in Review

Root Financial Partners opened a new position in Vir Biotechnology (VIR) in Q3 2026: 305 shares worth $3.41K. The stake represents ﹤0.01% of the portfolio and ranks #2388 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in VIR as recently as Q1 2026.

Root Financial Partners first reported a position in VIR in Q1 2026 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Root Financial Partners held 305 shares of Vir Biotechnology worth $3.41K as of Q3 2026.
  • Vir Biotechnology was a new Root Financial Partners position in Q3 2026.
  • Vir Biotechnology made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2388 holding.
  • Root Financial Partners first reported a position in Vir Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 135 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.